Enhanced dizocilpine efficacy in heterozygous reeler mice relates to GABA turnover downregulation

Neuropharmacology

Volumn 46, Issue 8, 2004, Pages 1070-1081

  Carboni, G ^a   Tueting, P ^a   Tremolizzo, L ^a   Sugaya, I ^a   Davis, J ^a   Costa, E ^a   Guidotti, A ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Cognition; Dizocilpine; GABA; Glutamate; Heterozygous reeler mice; Reelin

Indexed keywords

4 AMINOBUTYRIC ACID; DIZOCILPINE; GLUTAMIC ACID; MESSENGER RNA; NEUROPEPTIDE; REELIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SIZE; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITIC SPINE; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; FEAR; GABAERGIC TRANSMISSION; HETEROZYGOTE; HIPPOCAMPUS; MALE; MAZE TEST; MOUSE; MOUSE STRAIN; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; OLFACTORY DISCRIMINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STEREOTYPY; WILD TYPE;

ANIMALS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; ISOENZYMES; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NEUROLOGIC MUTANTS; MOTOR ACTIVITY;

EID: 1942436855     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.02.001     Document Type: Article

References (44)

1. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E. Jr., Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Archives of General Psychiatry. 52:1995;258-266.
2. Ballmaier M., Zoli M., Leo G., Agnati L.F., Spano P. Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophrenia. European Journal of Neuroscience. 15:2002;1197-1205.
3. Bertilsson L., Mao C.C., Costa E. Application of principles of steady-state kinetics to the estimation of gamma-aminobutyric acid turnover rate in nuclei of rat brain. Journal of Pharmacology and Experimental Therapeutics. 200:1977;277-284.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 72:1976;248-254.
5. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., Carlsson M.L. Interactions between monoamines, glutamate and GABA in schizophrenia: new evidence. Annual Review of Pharmacology and Toxicology. 41:2001;237-260.
6. Condie B.G., Bain G., Gottlieb D.I., Capecchi M.R. Cleft palate in mice with a targeted mutation in the gamma-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67. Proceedings of the National Academy of Science, USA. 94:1997;11451-11455.
7. Costa E., Davis J., Grayson D.R., Guidotti A., Pappas G.D., Pesold C. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiology of Disease. 8:2001;723-742.
8. Costa E., Davis J., Pesold C., Tueting P., Guidotti A. The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Current Opinion in Pharmacology. 2:2002a;56-62.
9. Costa E., Chen Y., Davis J., Noh J.S., Tremolizzo L., Veldic M., Grayson D.R., Guidotti A. Reelin and schizophrenia: a disease at the interface of the genome and the epigenome. Molecular Interventions. 2:2002b;47-57.
10. Danysz W., Wroblewski J.T., Costa E. Learning impairment in rats by N-methyl-D-aspartate receptor antagonists. Neuropharmacology. 27:1988;653-656.
11. D'Arcangelo G., Miao G.G., Curran T. Detection of the reelin breakpoint in reeler mice. Brain Research Molecular Brain Research. 39:1996;234-236.
12. Dong E., Caruncho H., Liu W.S., Smalheiser N.R., Grayson D.R., Costa E., Guidotti A. A reelin-integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes. Proceedings of the National Academy of Science, USA. 100:2003;5479-5484.
13. Fatemi S.H., Earle J.A., McMenomy T. Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Molecular Psychiatry. 5:2000;654-663.
14. Feng J., Yan Z., Ferreira A., Tomizawa K., Liauw J.A., Zhuo M., Allen P.B., Ouimet C.C., Greengard P. Spinophilin regulates the formation and function of dendritic spines. Proceedings of the National Academy of Science, USA. 97:2000;9287-9292.
15. Ferrarese C., Guidotti A., Costa E., Miletich R.S., Rice K.C., de Costa B.R., Fulham M.J., Di Chiro G. In vivo study of NMDA-sensitive glutamate receptor by fluorothienylcyclohexylpiperidine [correction of fluorothienylcycloexylpiperidine], a possible ligand for positron emission tomography. Neuropharmacology. 30:1991;899-905.
16. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., Barnes T.R., Hirsch S.R. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. Journal of Neurology and Neurosurgery in Psychiatry. 65:1998;446-453.
17. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Archives of General Psychiatry. 57:2000;65-73.
18. Grunze H.C., Rainnie D.G., Hasselmo M.E., Barkai E., Hearn E.F., McCarley R.W., Greene R.W. NMDA-dependent modulation of CA1 local circuit inhibition. Journal of Neuroscience. 16:1996;2034-2043.
19. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., Costa E. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Archives of General Psychiatry. 57:2000;1061-1069.
20. Heckers S., Stone D., Walsh J., Shick J., Koul P., Benes F.M. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Archives of General Psychiatry. 59:2002;521-529.
21. Kash S.F., Johnson R.S., Tecott L.H., Noebels J.L., Mayfield R.D., Hanahan D., Baekkeskov S. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proceedings of the National Academy of Science, USA. 94:1997;14060-14065.
22. Krystal J.H., Belger A., D'Souza D.C., Anand A., Charney D.S., Aghajanian G.K., Moghaddam B. Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists. Neuropsychopharmacology. 21:1999;S143-S157.
23. Lacor P., Grayson D.R., Auta J., Sugaya I., Costa E., Guidotti A. Reelin secretion from glutamatergic neurons in culture is independent from neurotransmitter regulation. Proceedings of the National Academy of Science, USA. 97:2000;3556-3561.
24. Larson J., Hoffman J.S., Guidotti A., Costa E. Olfactory discrimination learning deficit in heterozygous reeler mice. Brain Research. 971:2003;40-46.
25. Lewis D.A., Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron. 28:2000;325-334.
26. Li C.S., Lin W.H., Yang Y.Y., Huang C.C., Chen T.W., Chen Y.C. Impairment of temporal attention in patients with schizophrenia. Neuroreport. 13:2002;1427-1430.
27. Liu W.S., Pesold C., Rodriguez M.A., Carboni G., Auta J., Lacor P., Larson J., Condie B.G., Guidotti A., Costa E. Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proceedings of the National Academy of Science, USA. 98:2001;3477-3482.
28. Mohn A.R., Gainetdinov R.R., Caron M.G., Koller B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 98:1999;427-436.
29. Mountcastle V.B. Perceptual Neuroscience: The Cerebral Cortex. 1998;Harvard University Press, Cambridge, MA.
30. Mrzljak L., Levey A.I., Goldman-Rakic P.S. Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission. Proceedings of the National Academy of Science, USA. 90:1993;5194-5198.
31. Olney J.W., Farber N.B. NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology. 13:1995;335-345.
32. Pappas G.D., Kriho V., Pesold C. Reelin in the extracellular matrix and dendritic spines of the cortex and hippocampus: a comparison between wild type and heterozygous reeler mice by immunoelectron microscopy. Journal of Neurocytology. 30:2001;413-425.
33. Rodriguez M.A., Pesold C., Liu W.S., Kriho V., Guidotti A., Pappas G.D., Costa E. Colocalization of integrin receptors and reelin in dendritic spine postsynaptic densities of adult nonhuman primate cortex. Proceedings of the National Academy of Science, USA. 97:2000;3550-3555.
34. Rodriguez M.A., Caruncho H.J., Costa E., Pesold C., Liu W.S., Guidotti A. In Patas monkey, glutamic acid decarboxylase-67 and reelin mRNA coexpression varies in a manner dependent on layers and cortical areas. Journal of Comparative Neurology. 451:2002;279-288.
35. Romeo E., Cheney D.L., Zivkovic I., Costa E., Guidotti A. Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia: putative role for allopregnanolone. Journal of Pharmacology and Experimental Therapeutics. 270:1994;89-96.
36. Selemon L.D., Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biological Psychiatry. 45:1999;17-25.
37. Sharp F.R., Tomitaka M., Bernaudin M., Tomitaka S. Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? Trends in Neuroscience. 24:2001;330-334.
38. Shelton R.C., Karson C.N., Doran A.R., Pickar D., Bigelow L.B., Weinberger D.R. Cerebral structure pathology in schizophrenia: evidence for a selective prefrontal cortical defect. American Journal of Psychiatry. 145:1988;154-163.
39. Steward O., Worley P. Local synthesis of proteins at synaptic sites on dendrites: role in synaptic plasticity and memory consolidation? Neurobiology of Learning and Memory. 78:2002;508-527.
40. Tremolizzo L., Carboni G., Ruzicka W.B., Mitchell C.P., Sugaya I., Tueting P., Sharma R., Grayson D.R., Costa E., Guidotti A. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proceedings of the National Academy of Science, USA. 99:2002;17095-17100.
41. Tsai G., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annual Review of Pharmacology and Toxicology. 42:2002;165-179.
42. Tueting P., Costa E., Dwivedi Y., Guidotti A., Impagnatiello F., Manev R., Pesold C. The phenotypic characteristics of heterozygous reeler mouse. Neuroreport. 10:1999;1329-1334.
43. Veldic M., Caruncho H.J., Liu W.S., Davis J., Satta R., Grayson D.R., Guidotti A., Costa E. DNA methyltransferase1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proceedings of the National Academy of Science, USA. 101:2004;348-353.
44. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., Lewis D.A. Decreased glutamic acid decarboxylase 67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Archives of General Psychiatry. 57:2000;237-245.